-
Patent Agency Ranking
公开(公告)号：US20160215065A1
公开(公告)日：2016-07-28
申请号：US15094843
申请日：2016-04-08
Applicant: Genentech, Inc.
Inventor： Shuo-Yen Jack LIN , Daniel K. KIRCHHOFER , Menno VAN LOOKEREN CAMPAGNE
IPC: C07K16/40
CPC classification number: C07K16/40 , A61K2039/505 , C07K16/24 , C07K2317/14 , C07K2317/24 , C07K2317/33 , C07K2317/54 , C07K2317/55 , C07K2317/622 , C07K2317/76 , C07K2317/92
Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
Abstract translation: 本发明提供了NSP4抑制剂（例如抗NSP4抗体）及其使用方法。
-
公开(公告)号：US20180371107A1
公开(公告)日：2018-12-27
申请号：US15958977
申请日：2018-04-20
Applicant: Genentech, Inc.
Inventor： Shuo-Yen Jack LIN , Daniel K. KIRCHHOFER , Menno VAN LOOKEREN CAMPAGNE
Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
-
公开(公告)号：US20130344085A1
公开(公告)日：2013-12-26
申请号：US13918755
申请日：2013-06-14
Applicant: Genentech, Inc.
Inventor： Yan WU , Cecilia Pui Chi CHIU , Daniel K. KIRCHHOFER , Andrew PETERSON , Ganesh A. KOLUMAM , Monica Kong BELTRAN , Paul MORAN , Wei LI , Xanthe LAM , Lin LUIS , Ada HUI , Whittemore TINGLEY , John Douglas DAVIS , Nageshwar R. BUDHA
IPC: C07K16/40
CPC classification number: C07K16/40 , A61K39/39591 , A61K2039/505 , C07K2317/34 , C07K2317/55 , C07K2317/76 , C07K2317/92 , C07K2317/94
Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
Abstract translation: 本发明提供抗PCSK9抗体，制剂，给药方案及其使用方法。
-
公开(公告)号：US20240067752A1
公开(公告)日：2024-02-29
申请号：US18474445
申请日：2023-09-26
Applicant: Genentech, Inc.
Inventor： Robert F. KELLEY , Daniel K. KIRCHHOFER , Joyce LAI , Chingwei V. LEE , Wei-Ching LIANG , Michael T. LIPARI , Kelly M. LOYET , Tao SAI , Menno VAN LOOKEREN CAMPAGNE , Yan WU , Germaine FUH
IPC: C07K16/40 , A61K39/395
CPC classification number: C07K16/40 , A61K39/3955 , A61K2039/507 , C07K2317/24 , C07K2317/34 , C07K2317/53 , C07K2317/55 , C07K2317/92 , C07K2317/94
Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
-
公开(公告)号：US20170145113A1
公开(公告)日：2017-05-25
申请号：US15336171
申请日：2016-10-27
Applicant: Genentech, Inc.
Inventor： Robert F. KELLEY , Daniel K. KIRCHHOFER , Joyce LAI , Chingwei V. LEE , Wei-Ching LIANG , Michael T. LIPARI , Kelly M. LOYET , Tao SAI , Menno VAN LOOKEREN CAMPAGNE , Yan WU , Germaine FUH
IPC: C07K16/40
Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
-
-
-
-
Search Results
5
records
(took 0.015 seconds)
